Crescent Biopharma, Inc. · NASDAQ:CBIO

Fairmount Healthcare Fund II L.P. bought 853,450 Crescent Biopharma, Inc. shares (Form 4)

Traded Jul 16, 2026 · Filed Jul 20, 2026

On Jul 16, 2026, Fairmount Healthcare Fund II L.P. (Director, 10% owner) bought 853,450 Crescent Biopharma, Inc. shares at US$14.50 for US$12.4M, leaving 3,601,316 shares. Filed Jul 20, 2026 (Form 4).

Bought
853,450 shares
Price
US$14.50
Value
US$12.4M
Holding after
3,601,316 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 16, 2026Ordinary SharesBuy853,450US$14.503,601,316Indirect

Source

View original at SEC

Related